Skip to main content
HR+/HER2− BC: Adjuvant abemaciclib+ET shows sustained positive benefit-risk profile
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
HR+/HER2− BC: Adjuvant abemaciclib+ET shows sustained positive benefit-risk profile
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Epidermal Growth Factor Receptor
0
0.6
Breast
0
0.43
Cancer
0
0.43
Endocrine Therapy
0
0.65
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
1
Ob/Gyn & Women's Health
0
0.78
Edit Tags